Last update :
18/06/2021
References   References 4532  
Type : Manufacturer

Research teams :
Authors :
Title : Atezolizumab (Tecentriq®) - Summary of Product Characteristics
Reference : Roche Products Limited 2021

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionAtezolizumab Anticancer drug
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 3.2 >> 16.8 mg/ml 2-8°C Not specified
30 Day
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 3.2 >> 16.8 mg/ml <30°C Not specified
24 Hour
Stability in solutions Polypropylene Sodium chloride 0,9% 3.2 >> 16.8 mg/ml 2-8°C Not specified
30 Day
Stability in solutions Polypropylene Sodium chloride 0,9% 3.2 >> 16.8 mg/ml <30°C Not specified
24 Hour
Stability in solutions Polyethylene Sodium chloride 0,9% 3.2 >> 16.8 mg/ml 2-8°C Not specified
30 Day
Stability in solutions Polyethylene Sodium chloride 0,9% 3.2 >> 16.8 mg/ml <30°C Not specified
24 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 3.2 >> 16.8 mg/ml 2-8°C Not specified
30 Day
Stability in solutions Polyolefine Sodium chloride 0,9% 3.2 >> 16.8 mg/ml <30°C Not specified
24 Hour

  Mentions Légales